deramiocel
deramiocel: sourced relationships with 1 company · 2 clinical trials tracked.
deramiocel evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
How could deramiocel → CAPR affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence8 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| CAPRICOR THERAPEUTICS, INC. (CAPR) Muscular Dystrophies; Duchenne Muscular Dystrophy | Phase 3 |
Clinical Trial Registry Records (2)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Human Allogeneic Cardiosphere-Derived Cells for the Treatment of Duchenne Muscular Dystrophy
Primary endpoint: Change in the upper limb function
Open-Label Extension of the HOPE-2 Duchenne Muscular Dystrophy Trial
Primary endpoint: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) From Baseline Through Month 12
Frequently asked questions
Which companies have sourced relationships with deramiocel?
deramiocel has dated SEC/FDA relationship records for CAPRICOR THERAPEUTICS, INC..
How many clinical trials involve deramiocel?
BioSniper tracks 2 clinical trials involving deramiocel.